Jon Biro
About Jon C. Biro
Independent director appointed in February 2025; age 59. Jon Biro is a CPA and seasoned financial executive with prior public-company CFO roles (Harte Hanks, Exterran, Consolidated Graphics, ICO, Inc.), audit training at PricewaterhouseCoopers, and board experience at Aspect Medical Systems and Crown Crafts. He holds a B.A. in Psychology with a minor in Economics from The University of Texas at Austin and an M.S. in Accountancy from the University of Houston; currently serves as an Operating Partner/Consultant to Snow Peak Capital, LLC and sits on private-company boards (Sandy Alexander; Vision Plastics New Zealand). The Board cites his extensive finance, governance, and oil & gas industry knowledge as qualifications to serve .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Harte Hanks (public) | Chief Financial Officer | Not disclosed | Finance leadership; public company reporting |
| Exterran (public) | Chief Financial Officer | Not disclosed | Finance; oilfield services expertise |
| Consolidated Graphics (public) | Chief Financial Officer | Not disclosed | Finance; commercial printing exposure |
| ICO, Inc. (public) | Board Member; Interim CEO | Not disclosed | Governance and operational leadership |
| PricewaterhouseCoopers | Auditor | Early career (not dated) | Audit and accounting foundations |
External Roles
| Organization | Role | Tenure | Public/Private | Notes |
|---|---|---|---|---|
| Snow Peak Capital, LLC | Operating Partner & Consultant | Since 2021 | Private | Portfolio operations advisory |
| Sandy Alexander | Board Member | Not disclosed | Private | Commercial printing portfolio company |
| Vision Plastics New Zealand Ltd. | Board Member | Not disclosed | Private | Plastics processing |
| Aspect Medical Systems | Public Company Board Member (prior) | Not disclosed | Public (prior) | Prior public directorship |
| Crown Crafts | Public Company Board Member (prior) | Not disclosed | Public (prior) | Prior public directorship |
Board Governance
-
Committee memberships: Audit Committee; Nominating & Corporate Governance Committee; Compensation Committee. All members of these committees are independent under SEC and NASDAQ rules .
-
Committee chair roles: Audit Committee chaired by David B. Brown; Nominating & Corporate Governance chaired by Robert J. McNally; Compensation Committee chaired by David B. Brown; Independent Chairman serves as ex-officio non-paid member of all committees .
-
Audit Committee financial expert: The Board determined that Brown, Biro, and McNally qualify as “audit committee financial experts” under SEC regulations .
-
Independence: Four of five nominees are independent; committee independence affirmed above .
-
Attendance: Company expects full engagement; in 2024, directors attended at least 75% of Board and committee meetings; all directors attended the 2024 Annual Meeting (contextual; Biro appointed in 2025) .
-
Meeting cadence (2024):
Body Number of Meetings Board of Directors 8 Audit Committee 9 Nominating & Corporate Governance 5 Compensation Committee 7 Unanimous Consent 8 -
Governance policies: Majority voting in uncontested elections adopted Feb 19, 2025; anti-hedging/pledging; ownership guidelines; refreshed charters (Audit Apr 2025; Nominating Sep 2024; Compensation Dec 2024) .
-
Clawback: Robust recoupment policy covering restatements and misconduct, with multiple recovery mechanisms; referenced in 10-K Exhibit 97 .
Fixed Compensation
-
2025 director compensation schedule:
Component Amount (USD) Annual cash retainer – Non-Employee Director $45,000 Independent Chairman additional retainer $40,000 Audit Chair $10,000 Audit Member $7,500 Compensation Chair $7,500 Compensation Member $6,000 Nominating & Governance Chair $5,000 Nominating & Governance Member $5,000 Annual equity grant – Non-Employee Director $75,000 (RS) Annual equity grant – Independent Chairman $85,000 (RS) -
2024 director grant details (equity vesting and share counts):
Grant Date Pricing Basis Chairman Shares Other Director Shares Vesting July 25, 2024 30-day avg closing price $8.81 9,644 8,509 1-year vest -
Special projects compensation: Policy created Dec 2024; $85,000 total awarded to four independent directors in Jan 2025 (pre-Biro appointment) .
-
2024 non-employee directors’ compensation summary (Biro appointed in Feb 2025; no 2024 fees):
Name Cash Fees Stock Awards Special Project Comp Total Jon C. Biro — — — — (appointed Feb 2025; no 2024 fees)
Performance Compensation
- Director equity structure: Independent non-employee directors receive annual restricted stock grants that vest over one year; directors may use 10b5-1 plans post-vesting to sell shares for tax coverage .
- Performance metrics tied to director compensation: Not disclosed (company’s performance-based LTIs and ROE targets pertain to executives, not directors) .
| Performance Metric | Applicable to Director Pay? | Notes |
|---|---|---|
| TSR percentile | Not disclosed for directors | Exec LTIs include ROE-based component; directors receive time-based RS |
| ROE targets | Not disclosed for directors | Executive LTIs include multi-year consolidated ROE targets |
| ESG goals | Not disclosed for directors | No director-specific metrics disclosed |
Other Directorships & Interlocks
| Company/Organization | Role | Public/Private | Potential Interlock/Conflict |
|---|---|---|---|
| Snow Peak Capital portfolio (Sandy Alexander) | Board Member | Private | No related-party transactions disclosed in 2024 |
| Vision Plastics New Zealand Ltd. | Board Member | Private | No related-party transactions disclosed in 2024 |
| Aspect Medical Systems | Prior Public Board Member | Public (prior) | None disclosed |
| Crown Crafts | Prior Public Board Member | Public (prior) | None disclosed |
- Related party and conflicts: Company reports no related party transactions in 2024; anti-hedging/pledging and insider trading pre-clearance required .
Expertise & Qualifications
- Audit committee financial expert designation (SEC-defined) .
- Deep finance, accounting, corporate governance, and oil & gas sector experience .
- Board skills matrix highlights corporate governance, finance, capital markets, risk, cybersecurity, and international experience across nominees; Biro’s biography underscores finance and governance strengths .
Equity Ownership
-
Beneficial ownership as of April 28, 2025:
Holder Shares Owned Options Deferred Shares Total % Outstanding Jon C. Biro 1,722 — — 1,722 <0.5% -
Unvested shares: As of April 28, 2025, Biro held 1,722 unvested RS with no voting rights .
-
Ownership guidelines:
Group Guideline Multiple Compliance Status Independent Directors 3.0x Annual Base Cash Retainer All directors “in compliance” with guideline framework; Biro had not received grants as of Jan 31, 2025 and shows “No” achieved status but has 5 years to meet guidelines -
Hedging/pledging: Prohibited; directors must pre-notify CEO/CFO for securities transactions .
-
Pledging of shares: Prohibited (RED FLAG mitigated) .
Governance Assessment
-
Strengths:
- Triple-committee membership and independence enhance board oversight; audit financial expert designation strengthens financial reporting and controls .
- Majority voting in uncontested elections and refreshed committee charters signal governance quality; anti-hedging/pledging and clawback policies align with investor protection .
- Ownership guidelines (3x retainer for directors) and one-year vesting improve alignment and transparency; directors have five years to reach targets .
-
Watch items:
- New appointee with small current equity position (1,722 unvested shares) and not yet meeting guideline “achieved” status as of Jan 31, 2025; however, within the compliance window (5 years) .
- External private board roles and consulting (Snow Peak Capital portfolio companies) should continue to be monitored for any potential related-party dealings; company reports none in 2024 .
-
Attendance and engagement:
- Company-standard: directors expected to attend Board/committee meetings and Annual Meeting; 2024 attendance ≥75% and full Annual Meeting attendance (contextual to culture; Biro appointed in 2025) .
-
Compensation structure:
- Competitive director pay confirmed by Willis Towers Watson; 2025 program unchanged; equity is time-based RS, not performance-based—consistent with market practice, but performance-linked director pay is not used .
-
RED FLAGS:
- None identified in the proxy for Biro: no related-party transactions; hedging/pledging prohibited; no pledging disclosed; no attendance issues disclosed .
Overall implication: Biro’s audit expertise and multi-industry finance background bolster board effectiveness, with current safeguards (clawback, anti-hedging, majority voting) supporting investor confidence. Equity alignment should improve as grants vest and guideline accumulation progresses over the 5-year window .